Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Minor: Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India Interventions modified
- Minor: NICU-to-Home Dyadic Support for Very Preterm Infants and Families Start date pushed from Nov 16, 2026 to Nov 30, 2026
- Minor: Cognitive Training · Eating Disorders Study completion pushed from Jul 2026 to Jul 2032
- Minor: Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL Trial completed
- Minor: IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: Mesothelin-Targeting Logic-gated CAR T, · Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression Enrollment closed, study ongoing
- Minor: SIM0278 · Moderate to Severe Atopic Dermatitis Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Minor: MAXPIRe · Axatilimab · Idiopathic Pulmonary Fibrosis (IPF) Trial completed
- Minor: RGX-314 Gene Therapy Administered in the Suprachoroidal Space · Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME) Trial completed
- Minor: FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) Trial completed
- Minor: LY4268989 (MORF 057) in Healthy Participants Trial completed
- Minor: Research Into the Safety of a New Agent (VT-5006) · and Without Parkinson's Disease Trial completed
- Minor: IBI3011 Trial completed
- Minor: Cardiac Performance System (CPS) Trial completed
- Minor: Vimida Trial completed
- Minor: Specified Drug-use Survey of Leqvio for s.c. Injection Trial completed
- Minor: Probiotic Supplementation on Stress and Anxiety in Students Trial completed
- Minor: Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial Enrollment closed, study ongoing
- Minor: Gastrointestinal Discomfort and Infections in Healthy Term Infants Trial completed
- Minor: Specified Drug-use Surveillance of Fabhalta Capsules Trial completed
- Minor: New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors Enrollment closed, study ongoing
- Minor: 9-Valent Human Papillomavirus Recombinant Vaccine · Idiopathic CD4 T Cell Lymphocytopenia Trial completed
- Minor: Emicizumab · Type 3 Von Willebrand Disease Primary completion pushed from Apr 30, 2027 to Oct 6, 2027
- Minor: Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally Advanced Rectal Cancer Primary completion pushed from Dec 12, 2029 to Mar 13, 2030
- Minor: IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD Trial status changed: Not Yet Recruiting → Active, Not Recruiting
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates